Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 249

1.

Evaluating inputs of failure modes and effects analysis in identifying patient safety risks.

Simsekler MCE, Kaya GK, Ward JR, Clarkson PJ.

Int J Health Care Qual Assur. 2019 Feb 11;32(1):191-207. doi: 10.1108/IJHCQA-12-2017-0233.

2.

An integrated, accurate, rapid, and economical handheld consumer gluten detector.

Zhang J, Portela SB, Horrell JB, Leung A, Weitmann DR, Artiuch JB, Wilson SM, Cipriani M, Slakey LK, Burt AM, Dias Lourenco FJ, Spinali MS, Ward JR, Seit-Nebi A, Sundvor SE, Yates SN.

Food Chem. 2019 Mar 1;275:446-456. doi: 10.1016/j.foodchem.2018.08.117. Epub 2018 Sep 1.

3.

A framework to support risk assessment in hospitals.

Kaya GK, Ward JR, Clarkson PJ.

Int J Qual Health Care. 2019 Jun 1;31(5):393-401. doi: 10.1093/intqhc/mzy194.

4.

Comparing and Contrasting the Effects of Drosophila Condensin II Subunit dCAP-D3 Overexpression and Depletion in Vivo.

Deutschman E, Ward JR, Ho-A-Lim KT, Alban TJ, Zhang D, Willard B, Lemieux ME, Lathia JD, Longworth MS.

Genetics. 2018 Oct;210(2):531-546. doi: 10.1534/genetics.118.301344. Epub 2018 Aug 1.

5.

Diagnostic difficulties in the radiological assessment of subscapularis tears.

Ward JRN, Lotfi N, Dias RG, McBride TJ.

J Orthop. 2018 Jan 16;15(1):99-101. doi: 10.1016/j.jor.2018.01.016. eCollection 2018 Mar.

6.

Design for patient safety: a systems-based risk identification framework.

Simsekler MCE, Ward JR, Clarkson PJ.

Ergonomics. 2018 Aug;61(8):1046-1064. doi: 10.1080/00140139.2018.1437224. Epub 2018 Feb 15.

7.

Evaluation of system mapping approaches in identifying patient safety risks.

Simsekler MCE, Ward JR, Clarkson PJ.

Int J Qual Health Care. 2018 Apr 1;30(3):227-233. doi: 10.1093/intqhc/mzx176.

8.

Condensin II and GAIT complexes cooperate to restrict LINE-1 retrotransposition in epithelial cells.

Ward JR, Vasu K, Deutschman E, Halawani D, Larson PA, Zhang D, Willard B, Fox PL, Moran JV, Longworth MS.

PLoS Genet. 2017 Oct 13;13(10):e1007051. doi: 10.1371/journal.pgen.1007051. eCollection 2017 Oct.

9.

A participatory systems approach to design for safer integrated medicine management.

Jun GT, Canham A, Altuna-Palacios A, Ward JR, Bhamra R, Rogers S, Dutt A, Shah P.

Ergonomics. 2018 Jan;61(1):48-68. doi: 10.1080/00140139.2017.1329939. Epub 2017 Jun 2.

PMID:
28506152
10.

Targeting Neutrophilic Inflammation Using Polymersome-Mediated Cellular Delivery.

Robertson JD, Ward JR, Avila-Olias M, Battaglia G, Renshaw SA.

J Immunol. 2017 May 1;198(9):3596-3604. doi: 10.4049/jimmunol.1601901. Epub 2017 Mar 13.

11.

National Surveys of Military Personnel, Nursing Students, and the Public: Drivers of Military Nursing Careers.

Donelan K, Romano C, Buerhaus P, DesRoches C, Applebaum S, Ward JR, Schoneboom BA, Hinshaw AS.

Mil Med. 2016 Oct;181(10):1391. No abstract available.

PMID:
27753584
12.

Making the Case for Palliative Care at the System Level: Outcomes Data.

Bharadwaj P, Helfen KM, Deleon LJ, Thompson DM, Ward JR, Patterson J, Yennurajalingam S, Kim JB, Zimbro KS, Cassel JB, Bleznak AD.

J Palliat Med. 2016 Mar;19(3):255-8. doi: 10.1089/jpm.2015.0234. Epub 2016 Feb 5.

PMID:
26849002
13.

Trust-level risk identification guidance in the NHS East of England.

Simsekler MC, Card AJ, Ward JR, Clarkson PJ.

Int J Risk Saf Med. 2015;27(2):67-76. doi: 10.3233/JRS-150651.

PMID:
26410009
14.

Adoption of preventive behaviors in response to the 2009 H1N1 influenza pandemic: a multiethnic perspective.

SteelFisher GK, Blendon RJ, Kang M, Ward JR, Kahn EB, Maddox KE, Lubell KM, Tucker M, Ben-Porath EN.

Influenza Other Respir Viruses. 2015 May;9(3):131-42. doi: 10.1111/irv.12306.

15.

Rebalancing risk management--Part 2: The Active Risk Control (ARC) Toolkit.

Card AJ, Ward JR, Clarkson PJ.

J Healthc Risk Manag. 2015;34(3):4-17. doi: 10.1002/jhrm.21160.

PMID:
25630281
16.

Characterization of TRIF selectivity in the AGP class of lipid A mimetics: role of secondary lipid chains.

Khalaf JK, Bowen WS, Bazin HG, Ryter KT, Livesay MT, Ward JR, Evans JT, Johnson DA.

Bioorg Med Chem Lett. 2015 Feb 1;25(3):547-53. doi: 10.1016/j.bmcl.2014.12.024. Epub 2014 Dec 17.

17.

Use of the Generating Options for Active Risk Control (GO-ARC) Technique can lead to more robust risk control options.

Card AJ, Simsekler MC, Clark M, Ward JR, Clarkson PJ.

Int J Risk Saf Med. 2014;26(4):199-211. doi: 10.3233/JRS-140636.

PMID:
25420762
18.

Rebalancing risk management--part 1: The Process for Active Risk Control (PARC).

Card AJ, Ward JR, Clarkson PJ.

J Healthc Risk Manag. 2014;34(2):21-30. doi: 10.1002/jhrm.21155.

PMID:
25319465
19.
20.

Toward "stable-on-the-table" enzymes: improving key properties of catalase by covalent conjugation with poly(acrylic acid).

Riccardi CM, Cole KS, Benson KR, Ward JR, Bassett KM, Zhang Y, Zore OV, Stromer B, Kasi RM, Kumar CV.

Bioconjug Chem. 2014 Aug 20;25(8):1501-10. doi: 10.1021/bc500233u. Epub 2014 Jul 30.

PMID:
25046001
21.

National surveys of military personnel, nursing students, and the public: drivers of military nursing careers.

Donelan K, Romano C, Buerhaus P, DesRoches C, Applebaum S, Ward JR, Schoneboom BA, Hinshaw AS.

Mil Med. 2014 May;179(5):565-72. doi: 10.7205/MILMED-D-13-00323. Erratum in: Mil Med. 2016 Oct;181(10 ):1391.

PMID:
24806503
22.

Serum and glucocorticoid-regulated kinase 1 regulates neutrophil clearance during inflammation resolution.

Burgon J, Robertson AL, Sadiku P, Wang X, Hooper-Greenhill E, Prince LR, Walker P, Hoggett EE, Ward JR, Farrow SN, Zuercher WJ, Jeffrey P, Savage CO, Ingham PW, Hurlstone AF, Whyte MK, Renshaw SA.

J Immunol. 2014 Feb 15;192(4):1796-805. doi: 10.4049/jimmunol.1300087. Epub 2014 Jan 15.

23.

Trust-level risk evaluation and risk control guidance in the NHS East of England.

Card AJ, Ward JR, Clarkson PJ.

Risk Anal. 2014 Aug;34(8):1469-81. doi: 10.1111/risa.12159. Epub 2013 Dec 16.

PMID:
24341726
24.

Generating Options for Active Risk Control (GO-ARC): introducing a novel technique.

Card AJ, Ward JR, Clarkson PJ.

J Healthc Qual. 2014 Sep-Oct;36(5):32-41. doi: 10.1111/jhq.12017. Epub 2013 Jun 17.

PMID:
23773575
25.

Pollinator-mediated selection on floral morphology: evidence for transgressive evolution in a derived hybrid lineage.

Anton KA, Ward JR, Cruzan MB.

J Evol Biol. 2013 Mar;26(3):660-73. doi: 10.1111/jeb.12083. Epub 2013 Jan 17.

26.

Public response to the 2009 influenza A H1N1 pandemic: a polling study in five countries.

SteelFisher GK, Blendon RJ, Ward JR, Rapoport R, Kahn EB, Kohl KS.

Lancet Infect Dis. 2012 Nov;12(11):845-50. doi: 10.1016/S1473-3099(12)70206-2. Epub 2012 Oct 5.

PMID:
23041199
27.

Getting to zero: evidence-based healthcare risk management is key.

Card AJ, Ward JR, Clarkson PJ.

J Healthc Risk Manag. 2012;32(2):20-7. doi: 10.1002/jhrm.21091.

PMID:
22996428
28.

Beyond FMEA: the structured what-if technique (SWIFT).

Card AJ, Ward JR, Clarkson PJ.

J Healthc Risk Manag. 2012;31(4):23-9. doi: 10.1002/jhrm.20101. Review.

PMID:
22528401
29.

Prenatally diagnosed fetal conditions in the age of fetal care: does who counsels matter?

Brown SD, Ecker JL, Ward JR, Halpern EF, Sayeed SA, Buchmiller TL, Mitchell C, Donelan K.

Am J Obstet Gynecol. 2012 May;206(5):409.e1-11. doi: 10.1016/j.ajog.2012.01.026. Epub 2012 Feb 14.

PMID:
22340943
30.

Balancing the dilution and oddity effects: decisions depend on body size.

Rodgers GM, Ward JR, Askwith B, Morrell LJ.

PLoS One. 2011;6(7):e14819. doi: 10.1371/journal.pone.0014819. Epub 2011 Jul 5.

31.

Regulation of neutrophil senescence by microRNAs.

Ward JR, Heath PR, Catto JW, Whyte MK, Milo M, Renshaw SA.

PLoS One. 2011 Jan 19;6(1):e15810. doi: 10.1371/journal.pone.0015810.

32.

Temporal interleukin-1beta secretion from primary human peripheral blood monocytes by P2X7-independent and P2X7-dependent mechanisms.

Ward JR, West PW, Ariaans MP, Parker LC, Francis SE, Crossman DC, Sabroe I, Wilson HL.

J Biol Chem. 2010 Jul 23;285(30):23147-58. doi: 10.1074/jbc.M109.072793. Epub 2010 May 21.

33.

Antagonistic interactions among coral-associated bacteria.

Rypien KL, Ward JR, Azam F.

Environ Microbiol. 2010 Jan;12(1):28-39. doi: 10.1111/j.1462-2920.2009.02027.x. Epub 2009 Aug 18.

PMID:
19691500
34.

A central role for monocytes in Toll-like receptor-mediated activation of the vasculature.

Ward JR, Francis SE, Marsden L, Suddason T, Lord GM, Dower SK, Crossman DC, Sabroe I.

Immunology. 2009 Sep;128(1):58-68. doi: 10.1111/j.1365-2567.2009.03071.x.

35.

Translational mini-review series on immunology of vascular disease: inflammation, infections and Toll-like receptors in cardiovascular disease.

Ward JR, Wilson HL, Francis SE, Crossman DC, Sabroe I.

Clin Exp Immunol. 2009 Jun;156(3):386-94. doi: 10.1111/j.1365-2249.2009.03886.x. Epub 2009 Mar 20. Review.

36.

A phosphatidylserine species inhibits a range of TLR- but not IL-1beta-induced inflammatory responses by disruption of membrane microdomains.

Parker LC, Prestwich EC, Ward JR, Smythe E, Berry A, Triantafilou M, Triantafilou K, Sabroe I.

J Immunol. 2008 Oct 15;181(8):5606-17.

37.

Differential and cell-type specific regulation of responses to Toll-like receptor agonists by ISO-1.

West PW, Parker LC, Ward JR, Sabroe I.

Immunology. 2008 Sep;125(1):101-10. doi: 10.1111/j.1365-2567.2008.02825.x. Epub 2008 Mar 18.

38.

Increases in cholinergic neurotransmission measured by using choline-sensitive microelectrodes: enhanced detection by hydrolysis of acetylcholine on recording sites?

Giuliano C, Parikh V, Ward JR, Chiamulera C, Sarter M.

Neurochem Int. 2008 Jun;52(7):1343-50. doi: 10.1016/j.neuint.2008.02.002. Epub 2008 Feb 14.

39.

The external nasal dilator: style over function?

Boggs GW, Ward JR, Stavrianeas S.

J Strength Cond Res. 2008 Jan;22(1):269-75. doi: 10.1519/JSC.0b013e31815f903e.

PMID:
18296986
40.

Pigmented epithelioid melanocytoma.

Ward JR, Brady SP, Tada H, Levin NA.

Int J Dermatol. 2006 Dec;45(12):1403-5. No abstract available.

PMID:
17184238
41.

Cooperative molecular and cellular networks regulate Toll-like receptor-dependent inflammatory responses.

Morris GE, Parker LC, Ward JR, Jones EC, Whyte MK, Brightling CE, Bradding P, Dower SK, Sabroe I.

FASEB J. 2006 Oct;20(12):2153-5. Epub 2006 Aug 25.

PMID:
16935934
42.

Coral diversity and disease in Mexico.

Ward JR, Rypien KL, Bruno JF, Harvell CD, Jordán-Dahlgren E, Mullen KM, Rodríguez-Martínez RE, Sánchez J, Smith G.

Dis Aquat Organ. 2006 Mar 23;69(1):23-31.

43.

Potentiation of TLR4 signalling by plasmin activity.

Ward JR, Dower SK, Whyte MK, Buttle DJ, Sabroe I.

Biochem Biophys Res Commun. 2006 Mar 10;341(2):299-303. Epub 2006 Jan 10.

PMID:
16413499
44.

Stable Symbiodinium composition in the sea fan Gorgonia ventalina during temperature and disease stress.

Kirk NL, Ward JR, Coffroth MA.

Biol Bull. 2005 Dec;209(3):227-34.

PMID:
16382170
45.

Agonists of toll-like receptor (TLR)2 and TLR4 are unable to modulate platelet activation by adenosine diphosphate and platelet activating factor.

Ward JR, Bingle L, Judge HM, Brown SB, Storey RF, Whyte MK, Dower SK, Buttle DJ, Sabroe I.

Thromb Haemost. 2005 Oct;94(4):831-8.

PMID:
16270639
46.

The low-toxicity versions of LPS, MPL adjuvant and RC529, are efficient adjuvants for CD4+ T cells.

Thompson BS, Chilton PM, Ward JR, Evans JT, Mitchell TC.

J Leukoc Biol. 2005 Dec;78(6):1273-80. Epub 2005 Oct 4.

PMID:
16204643
47.

Willan's itch and other causes of pruritus in the elderly.

Ward JR, Bernhard JD.

Int J Dermatol. 2005 Apr;44(4):267-73. Review.

PMID:
15811075
48.
49.

The elusive baseline of marine disease: are diseases in ocean ecosystems increasing?

Ward JR, Lafferty KD.

PLoS Biol. 2004 Apr;2(4):E120. Epub 2004 Apr 13.

50.

An analysis of medical device-related errors: prevalence and possible solutions.

Ward JR, Clarkson PJ.

J Med Eng Technol. 2004 Jan-Feb;28(1):2-21.

PMID:
14660181

Supplemental Content

Support Center